Poster Abstracts • OFID 2017:4 (Suppl 1) • S119 of piped water in El Salvador is by the ' Administracion Nacional de Acueductos y Alcantarillodos' (ANDA) agency in EL Salvador, contracted decentralized operators, and/or non-decentralized operators. Descriptive statistics was done to understand the study population and logistic regression was conducted to determine the association between STHI infection and drinking water supply in the study population.
Frequency of Combination Medications Associated with QTc Prolongation in a Travel

Background.
A common practice during a travel medicine clinic visit is to provide an antibiotic prescription for stand-by treatment of moderate-to-severe traveler's diarrhea. Ciprofloxacin/levofloxacin or azithromycin are often used for this purpose. These antibiotics have been implicated in prolonging the QTc interval. Medication lists of travelers can include non-antibiotic agents that can prolong the QTc interval as well. Hence, situations with cumulative QTc prolongation by multiple agents, with an attendant risk for associated arrhythmia, may be relatively common. They may warrant further risk assessment by the provider, such as obtaining an EKG. We quantified the frequency of potential drug-drug interactions in Travel Clinic patients in a retrospective review of a random 3-month cohort of patients who visited our Travel Clinic in 2016, and how often particular medications were prescribed. Whether an EKG was recommended by the provider because of perceived cumulative medication-related risk of QTc prolongation was recorded.
Methods.
A chart review, including medication lists, occurred for 158 consecutive patients who visited our Travel Clinic in a 3-month period. The number of patients taking specified medications with potential for QTc prolongation at the time of their Travel Clinic visit and the frequency of specific agents were tallied. Whether EKGs were recommended was recorded.
Results. 23/158 travel clinic patients (14.6%) were taking antidepressant medications with at least moderate potential for QTc prolongation when combined with a quinolone or azithromycin. An additional nine patients (5.7%) were prescribed multiple other agents with QTc prolongation potential at the conclusion of their Travel Clinic visit. An EKG for risk assessment was recommended by the Travel Clinic provider for seven patients (4.4%).
Conclusion. Travel Clinic patients often are prescribed medications that may enhance the QTc prolongation potential of antibiotics used for stand-by treatment of traveler's diarrhea. Possible drug-drug interactions that could increase risk for an arrhythmia warrant a careful medication history and risk assessment in the clinic.
Disclosures. All authors: No reported disclosures. Methods. We systematically collected clinical and epidemiological data from all patients clinically suspected with rickettsial diseases at three medical facilities in Boso Peninsula of Japan between 2004 and 2015. Indirect immunofluorescence assays were used, and eschar PCR/immunoperoxidase assays were also used for identifying the strain. SatScan™ was used for spatial cluster analysis.
Clinical and Epidemiological
Results. In total, 661 patients were enrolled, 44% were female, and the mean age was 64 years. Thirty-two patients were diagnosed as JSF, 204 were ST, and 97 were non-rickettsial diseases. Only one patient died of ST. Comparing to non-rickettsial diseases, patients with JSF and ST were significantly older, and more of them resided wooded area (P < 0.001). Spatial clusters were identified for both JSF (P < 0.001) and ST (P < 0.05). JSF occurred from April to October with a small peak in July, while 90.2% of ST was diagnosed in November and December. Both rash and eschar were detected in the majority of JSF (97%, 86%) and ST (96%, 87%). When compared with ST, purpura, and the rash on palms/soles were strongly associated with JSF (OR, 29.0, 61.1, respectively). However, patients were much less likely to complain their rash (27% JSF, 44% ST) and eschar (0% JSF, 2.5% ST). Moreover, 26% of JSF and 28% of ST cases did not present with apparent fever (≥37.5°C). All identified ST strains were Irie/ Kawasaki (16/22, 73%) or Hirano/Kuroki (6/22, 27%).
Conclusion. Although clinical picture of JSF and ST are similar, there are some clues to distinguish JSF from ST such as seasonality, geographical region, rash distribution on palms/soles, and the hemorrhagic nature of rash. Rickettsial cases may be underdiagnosed if clinical diagnosis relies on fever, rash, and eschar.
Disclosures. All authors: No reported disclosures. treatment guidelines were designed based on expert opinion considering clinical criteria for local treatment which influences feasibility of implementation of these treatment modalities. In this study, we evaluated the clinico-epidemiological profile and the eligibility for the use of local therapies with current guidelines of patients with CL at the Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM) from 2004 to 2014.
Clinico-Epidemiological Profile of Adolescent and Adult Patients with
Methods. A descriptive study was conducted based on clinical records of adolescents (≥12 years) and adults (≥18 years) with confirmed parasitological diagnosis of tegumentary leishmaniasis. Incomplete or unconfirmed records were excluded. We applied WHO criteria (≤3 lesions, longest diameter <5 cm, no disfiguring/incapacitating potential, no immunosuppression) and PAHO (single lesion, diameter ≤3 cm, any location except head and joints, absence of immunosuppression) to assess eligibility for local treatment.
Results. Among 3,691 records, a total of 1,834 met inclusion criteria. Fourteen percent of records were from adolescent patients and 86% were adults, all from southwestern Colombia. Regarding the clinical presentation of patients, most (57.3%) had a single lesion and 86.2% had ≤ 3 lesions with a median = 2 cm (IQR 1-2) . Lesions presented predominantly on upper limbs (40.9%), followed by lower limbs (23.2%). According to PAHO and WHO criteria, 18% (12.3% adult vs. 19 .3%, P = 0.007) and 44.4% (adolescents 42% vs. adults 43%, P = 0.45), respectively, were eligible for local therapies.
Conclusion. Local therapies have feasible use in this population with mild and uncomplicated clinical presentation; however, its applicability is limited to current management criteria. Individualized risk--benefit assessment may increase eligibility.
Disclosures. Background. Cat-scratch disease (CSD) has worldwide distribution and is the most frequent presentation of Bartonella henselae infection. Systemic CSD has mainly been reported in immunocompetent children and immunosuppressed adults. The aim of this study was to assess the clinical and laboratory findings of systemic CSD in immunocompetent adults.
Methods. A retrospective, cohort study of all consecutive, immunocompetent adult patients diagnosed with systemic CSD in 10-year period (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) , was conducted at the University Hospital for Infectious Diseases Zagreb. Diagnosis was established by serology (IgM > 1:20, IgG > 1:256 or the fourfold rise in IgG titer in the convalescent phase) or polymerase chain reaction (PCR).
Results. In total, 32 cases were identified, 23 males, mean age of 35 ± 16 years, and majority of them (96.9%) recalled cat exposure. Twenty-one patients (65.6%) presented as fever of unknown origin, nine (28.1%) with hepatosplenic form, one patient with oculoglandular with prolonged fever and one with parotitis. Thirty-one (96.9%) patients were febrile for the 8.4 ± 5.6 days before hospitalization. Only 18.8% had concomitant lymphadenitis, 59.4% had headache, 28.1% abdominal pain and respiratory symptoms, 37.5% hepatomegaly and 31.3% splenomegaly on clinical examination. All except one patient had elevated CRP (70.8 ± 46.9), 12 patients (37.5%) had elevated WBC, 7 patients (21.8%) had elevated aminotranspherases, and 4 patients (12.5%) had multiple spleen abscesses. The diagnosis was established after 5.2 ± 5.3 days of hospitalization. Thirty (93.7%) received antibiotic treatment for the mean duration of 11.4 ± 5.2 days (18 (56.2%) macrolides (3 in monotherapy), 16 (50%) β-lactams (in combination), three (9.37%) doxycycline monotherapy, five (15.6%) fluoroquinolones (2 in monotherapy), four (12.5%) rifampicin, and five (15.6%) gentamicin always in combination). The mean duration of fever on antibiotic therapy was 7.3 ± 5.8 days. All patients were cured without sequelae regardless of treatment.
Conclusion. Systemic CSD is not rare in healthy individuals. Since the diversity of the clinical manifestations in adults may be misleading, the infection should be suspected in patients with recent contact with a cat even despite the presence of lymphadenopathy.
Disclosures. All authors: No reported disclosures. October 5, 2017: 12:30 PM Background. Bacteremic brucellosis is an acute febrile disease often associated with digestive complaints and biological inflammatory syndrome. In this perspective, our study aimed to determine predictive factors of bacteremia in patients with brucellosis.
What Is Different
Methods. We conducted a retrospective study including all patients hospitalized with brucellosis between 1990 and 2014.
Results. We included 161 cases of brucellosis among which bacteremia was documented in 30 cases (18.6%). Mean age was of 39.6 ± 17 years. Brucella melitensis was solely isolated. In bacteremic brucellosis, there were more fever (93.3% vs. 78%; P = 0.049; HR=4), nausea (16.7% vs. 4.6%; P = 0.033; HR = 4.2), and splenomegaly (20% vs. 7.6%; P = 0.049; HR = 3). The acute form was significantly more common in bacteremic brucellosis (66.7% vs. 42%; P = 0.015; HR = 2.7). Bacteremic brucellosis patients had a significantly higher frequence of anemia (76.7% vs. 51.6%; P = 0.013; HR=3.2) and higher C-reactive protein value (85.5 ± 45 vs. 35 ± 20 mg/L; P < 0.001). Commonly used antimicrobial regimens consisted of rifampicin plus doxycycline given for 6 weeks in both bacteremic and non-bacteremic brucellosis (86.7% vs. 72%; P = 0.1). A favorable outcome was significantly associated with bacteremic brucellosis (73.3% vs. 52%; P = 0.03; HR=2.38). Multivariate analysis using logistic regression revealed that the presence of nausea (HR = 9; CI95% 14-60; P = 0.002), acute form of brucellosis (HR = 4.5; CI95% 1.2-17; P = 0.025) and C-reactive protein value (HR = 1.12; CI95% 1.1-1.2; P = 0.02) were independent predictors of bacteremic brucellosis.
Conclusion. Our study highlighted clinical and biological particularities of bacteremic brucellosis which may help clinicians to establish a prompt diagnosis and suitable treatment, two main conditions to improve patients' prognosis.
Disclosures. Background. Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, is endemic to Texas and has significant morbidity associated with its cardiac pathology. The Joint Base San Antonio-Lackland (JBSA) represents a healthcare system with universal coverage to its beneficiaries and its blood bank screens all firsttime blood donors for T. cruzi infection. Although there is a published, standardized approach for diagnosis and evaluation of Chagas disease in the United States, adherence to this approach has not been studied.
Methods. A retrospective chart review was performed on all persons who screened positive for T. cruzi on blood donation at JBSA from 2014 to 2016. Charts were reviewed to determine frequency and results of confirmatory testing, history and physical, EKG, and 30 second rhythm strip; outcomes of these evaluations were ascertained. Chagas disease was considered confirmed on the basis of positive EIA and TESA testing from the CDC and/or two different positive serologic tests.
Results. Of the 43,402 blood donors at JBSA, 23 screened positive for Chagas disease. Follow-up information was available on 22 (95.7%). Seventeen (77%) were military trainees and 18 (82%) were male. Patients had a mean of 2.5 (range 1-5) additional serologic tests, with 13 different combinations of confirmatory tests ordered, including 17 (77%) who had the initial screening test repeated. Two patients (9%), both from Texas, met criteria for Chagas disease. One of these was diagnosed with cardiomyopathy and underwent administrative separation from the Air Force. Eleven (50%) had Chagas disease excluded on the basis of two negative follow-up tests, and 9 (41%) had one negative follow-up test. All underwent history and physical, 15 (68%) had an EKG, and 5 (22%) had a 30 second rhythm strip. Fourteen (64%) were referred to infectious diseases.
Conclusion. Among a small cohort of active duty service members who screened positive for T. cruzi infection on blood donation, diagnostic workup, and evaluation varied considerably, despite universal access to no-cost medical care within a single system. Opportunities exist within the military health system to decrease heterogeneity and to improve evaluation of persons who screen positive in the future. 
